Turnstone Biologics Corp. (NASDAQ: TSBX) Stock Information | RedChip

Turnstone Biologics Corp. (NASDAQ: TSBX)


$0.4727
-0.0084 ( -2.15% ) 18.8K

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which areĀ referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Market Data


Open


$0.4727

Previous close


$0.4811

Volume


18.8K

Market cap


$11.23M

Day range


$0.4660 - $0.4850

52 week range


$0.4393 - $5.7500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 11 Jun 05, 2024
8-k 8K-related 12 May 13, 2024
10-q Quarterly Reports 72 May 13, 2024
def Proxies and info statements 5 Apr 22, 2024
ars Annual reports 1 Apr 22, 2024
8-k 8K-related 13 Apr 16, 2024
3 Insider transactions 2 Apr 16, 2024
4 Insider transactions 1 Apr 16, 2024
10-k Annual reports 94 Mar 22, 2024

Latest News